FR2186470A1 - Purine nucleoside nitrates - for treating cardiac insufficiency - Google Patents

Purine nucleoside nitrates - for treating cardiac insufficiency

Info

Publication number
FR2186470A1
FR2186470A1 FR7318902A FR7318902A FR2186470A1 FR 2186470 A1 FR2186470 A1 FR 2186470A1 FR 7318902 A FR7318902 A FR 7318902A FR 7318902 A FR7318902 A FR 7318902A FR 2186470 A1 FR2186470 A1 FR 2186470A1
Authority
FR
France
Prior art keywords
purine nucleoside
no2
cardiac insufficiency
nitrates
treating cardiac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7318902A
Other versions
FR2186470B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henning Berlin GmbH Chemie- und Pharmawerk
Original Assignee
Henning Berlin GmbH Chemie- und Pharmawerk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE19722226295 priority Critical patent/DE2226295A1/en
Application filed by Henning Berlin GmbH Chemie- und Pharmawerk filed Critical Henning Berlin GmbH Chemie- und Pharmawerk
Publication of FR2186470A1 publication Critical patent/FR2186470A1/en
Application granted granted Critical
Publication of FR2186470B1 publication Critical patent/FR2186470B1/fr
Application status is Expired legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Abstract

Novel title cpds are of formula (I): (R=NH2 or OH; R1 and R2=H or NO2; R3=NO2) and are prepd by reacting corresp. purine nucleoside with fuming HNO3 opt. mixed with acetic anhydride, pref. at between -70 degrees C and room temp. (I) are useful in treatment of cardiac insufficiency and also in purine nucleoside chemistry since the NO2 gps are relatively stable acids and bases but easily removed by hydrogenolysis.
FR7318902A 1972-05-30 1973-05-24 Expired FR2186470B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19722226295 DE2226295A1 (en) 1972-05-30 1972-05-30 Salpetersaeureester purine nucleosides and method for manufacturing the same

Publications (2)

Publication Number Publication Date
FR2186470A1 true FR2186470A1 (en) 1974-01-11
FR2186470B1 FR2186470B1 (en) 1976-06-11

Family

ID=5846334

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7318902A Expired FR2186470B1 (en) 1972-05-30 1973-05-24

Country Status (3)

Country Link
AT (1) AT323336B (en)
DE (1) DE2226295A1 (en)
FR (1) FR2186470B1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1758596A2 (en) * 2004-05-26 2007-03-07 Inotek Pharmaceuticals Corporation Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
US7732424B2 (en) 2005-11-30 2010-06-08 Inotek Pharmaceuticals Corporation Purine derivatives and methods of use thereof
US9278991B2 (en) 2012-01-26 2016-03-08 Inotek Pharmaceuticals Corporation Anhydrous polymorphs of [(2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)} methyl nitrate and processes of preparation thereof
US9289383B2 (en) 2010-03-26 2016-03-22 Inotek Pharmaceuticals Corporation Method of reducing intraocular pressure in humans
US9370530B2 (en) 2010-01-11 2016-06-21 Inotek Pharmaceuticals Corporation Combination, kit and method of reducing intraocular pressure
US9522160B2 (en) 2013-03-15 2016-12-20 Inotek Pharmaceuticals Corporation Ophthalmic formulations

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3595853A (en) * 1968-03-19 1971-07-27 Kohjin Co Ribofuranosyl cytosine and arabinofuranosyl cytosine derivatives
DE2105560A1 (en) * 1971-02-06 1972-09-07
FR2152507A1 (en) * 1971-09-10 1973-04-27 Hoffmann La Roche

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3595853A (en) * 1968-03-19 1971-07-27 Kohjin Co Ribofuranosyl cytosine and arabinofuranosyl cytosine derivatives
DE2105560A1 (en) * 1971-02-06 1972-09-07
FR2152507A1 (en) * 1971-09-10 1973-04-27 Hoffmann La Roche

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8609833B2 (en) 2004-05-26 2013-12-17 Inotek Pharmaceuticals Corporation Purine derivatives as adenosine A1 receptor agonists and methods of use thereof
EP1758596A4 (en) * 2004-05-26 2007-08-01 Inotek Pharmaceuticals Corp Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
US7423144B2 (en) 2004-05-26 2008-09-09 Inotek Pharmaceuticals Corporation Purine Derivatives as adenosine A1 receptor agonists and methods of use thereof
NO339450B1 (en) * 2004-05-26 2016-12-12 Inotek Pharmaceuticals Corp Purine derivatives as adenosine A1 receptor agonists, compositions containing same and uses thereof
EP2221307A1 (en) * 2004-05-26 2010-08-25 Inotek Pharmaceuticals Corporation Purine derivatives as adenosine A1 receptor agonists and methods of use thereof
AU2005249430B2 (en) * 2004-05-26 2011-06-23 Inotek Pharmaceuticals Corporation Purine derivatives as adenosine A1 receptor agonists and methods of use thereof
US8183224B2 (en) 2004-05-26 2012-05-22 Inotek Pharmaceuticals Corporation Purine derivatives as adenosine A1 receptor agonists and methods of use thereof
EP1758596A2 (en) * 2004-05-26 2007-03-07 Inotek Pharmaceuticals Corporation Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
US7732424B2 (en) 2005-11-30 2010-06-08 Inotek Pharmaceuticals Corporation Purine derivatives and methods of use thereof
US9370530B2 (en) 2010-01-11 2016-06-21 Inotek Pharmaceuticals Corporation Combination, kit and method of reducing intraocular pressure
US9289383B2 (en) 2010-03-26 2016-03-22 Inotek Pharmaceuticals Corporation Method of reducing intraocular pressure in humans
US9278991B2 (en) 2012-01-26 2016-03-08 Inotek Pharmaceuticals Corporation Anhydrous polymorphs of [(2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)} methyl nitrate and processes of preparation thereof
US9718853B2 (en) 2012-01-26 2017-08-01 Inotek Pharmaceuticals Corporation Anhydrous polymorphs of [(2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-YL)-3,4-dihydroxytetrahydrofuran-2-YL)] methyl nitrate and processes of preparation thereof
US9522160B2 (en) 2013-03-15 2016-12-20 Inotek Pharmaceuticals Corporation Ophthalmic formulations

Also Published As

Publication number Publication date
DE2226295A1 (en) 1973-12-20
FR2186470B1 (en) 1976-06-11
AT323336B (en) 1975-07-10

Similar Documents

Publication Publication Date Title
AT323181B (en) A process for the preparation of novel pyrrolo (3,4-b) pyrazine derivatives as well as acid addition salts of the
ES8801787A1 (en) A process for preparing acid amide benzoheterociclilalcanoicos
ES8800681A1 (en) Process for preparing imidazo (1,5-a) pyridine
CA986407A (en) Acid gas burner
CA1000730A (en) Manufacture of dicarboxylic acid
CS181244B2 (en) Method of producing salts of acid cephalosporine with basic aminoacids,selected from group contaning arginine and lysine
CA1001166A (en) Process for the production of substantially anhydrous percarboxylic acid solutions in organic solvents
SE7410237A (en)
AR216891A1 (en) lyophilic enzymic preparation and procedures to produce, for enzymic reaction and prepare the acid 6-amino-penicillanic
RO73345A (en) Process for the preparation of beta-amino-3-cephem-ol-4-carboxylic acid 7 -substitus derivatives
IE34917L (en) Ó-dipeptide esters of l-aspartic acid
ZM11574A1 (en) Improvements in or relating to the heat treatment of glasssheets
CA988620A (en) Electro-optically induced weak coupling of adjacent carbon dioxide laser modes
GB1303392A (en)
GB1073136A (en) Production of purine derivatives
FR2133024A5 (en) Bis-(4-nicotinoyloxyphenylthio) propanes - with hypocholesterolaemic and hypolipaemic activity
IE45812B1 (en) Treatment of infections with pseudomonic acid, salts or esters thereof
DE2159361A1 (en) Diacylamino-3-(5-nitro-2-furfurylidene) oxindoles - - with antibacterial and antimycotic activity
GB1077603A (en) A new amine and procss for its manufacture
DE2206826A1 (en) Intramolecularly crosslinked insulins - with reduced immunogenicity and prolonged activity
CH503747A (en) Pyrazinamidoguanidines neth 6 409 715 provided
DE2103387A1 (en) Compns of glucosamine hydrochloride and anti-rheumatic - agent - for treatment of arthrosis and arthritis,with reduced toxicit
AU4858772A (en) Cooling water pump, preferably of motorcar engines
RO68286A (en) Process for the preparation of acid dihydrate (d-alfa-amino-1,4-cyclohexiene-1-ilacetamido) deacetoxyphalosporanic
FR2020209A1 (en) Antibiotic acylxymethyl 7-(alpha-amino-alpha-phenyl- - acetamido)-3-methyl-delta-3-cephem-4-carboxylates

Legal Events

Date Code Title Description
ST Notification of lapse